WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced the availability of a final guidance titled "M15 General Principles for Model-Informed Drug Development," establishing an internationally harmonized framework for the planning, evaluation and documentation of evidence generated through model-informed drug development. The guidance was developed through the International Council for Harmonisation of Technical Require . . .

Click here for more information about our products